MassDevice.com +3 | The top 3 medtech stories for August 12, 2015

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.   3. Study: Edwards’ Sapien and Medtronic’s CoreValve outcomes are similar A new study published in the Journal of the American College of Cardiology found that patients treated with Edwards Lifesciences’s and Medtronic’s CoreValve showed similar results after 1 year. The 241-patient trial examined high-risk patients with symptomatic severe aortic stenosis 1 year after being treated with either Edwards’s Sapien balloon expanding or Medtronic’ self-expanding transcatheter heart valve.┬áRead more 2. Google restructuring puts Life Sciences & Calico group under new umbrella Google announced a corporate restructuring that places it under the new parent company Alphabet. The company highlighted the separation of its med-device developer Life Sciences business and human-longevity focused Calico division.┬áRead more 1. NxStage reveals next-gen hemo, peritoneal dialysis systems NxStage Medical announced 3 new products in the pipeline for the dialysis-focused device company during a conference call discussing their quarterly earnings. Included in the announcements was a next-generation portable hemodialysis system usa...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 3 Source Type: news